Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Short-Term Menatetrenone Therapy Increases Gamma-Carboxylation Of Osteocalcin With A Moderate Increase Of Bone Turnover In Postmenopausal Osteoporosis: A Randomized Prospective Study

NCT00548509 is registered in ClinicalTrials.gov with Eisai Limited as lead sponsor.

NCT NCT00548509
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00548509 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Short-Term Menatetrenone Therapy Increases Gamma-Carboxylation Of Osteocalcin With A Moderate Increase Of Bone Turnover In Postmenopausal Osteoporosis: A Randomized Prospective Study
Lead sponsor
Eisai Limited
Phase
Phase 4
Overall status
Completed
Start date
February 1, 2002
Completion date
January 31, 2013
Enrollment
131 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

osteoporosis